MH Group n = 41 | NMH Group n = 14 | p-value | |
---|---|---|---|
Data before PSL administration | |||
CAI | 13.3 (9–19) | 13.1 (10–17) | 0.493 |
Hb (g/dl) | 11 (7.5–12.9) | 12.6 (7.9–15.1) | 0.19 |
Alb (g/dl) | 3.4 (1.9–4.4) | 3.4 (2–4.6) | 0.889 |
CRP (mg/dl) | 3.9 (0.2–22.6) | 2.9 (0.04–11.9) | 0.636 |
Mayo scorea | 2.9 (2–3) | 3 (3) | 0.341 |
UCEIS scorea | 6.6 (4–8) | 7.4 (6–8) | 0.236 |
Data before TAC administration | |||
CAI | 12.9 (7–19) | 13.4 (11–17) | 0.593 |
Hb (g/dl) | 12 (7.5–14.9) | 12.9 (8.1–15.1) | 0.191 |
Alb (g/dl) | 3.3 (1.7–4.4) | 3.3 (2–4.6) | 0.838 |
CRP (mg/dl) | 3.5 (0.04–24.1) | 2.6 (0.04–10.4) | 0.525 |
Mayo score | 2.9 (2–3) | 3 (3) | 0.306 |
UCEIS score | 6.7 (4–8) | 7.2 (6–8) | 0.136 |
Time to achieve the target TAC trough level (days) | 3.1 (1–10) | 4.5 (1–9) | 0.07 |